Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The exomes of the NCI-60 panel: a genomic resource for cancer biology and systems pharmacology.

Cancer research - 15 Jul 2013

Abaan Ogan D, Polley Eric C, Davis Sean R, Zhu Yuelin J, Bilke Sven, Walker Robert L, Pineda Marbin, Gindin Yevgeniy, Jiang Yuan, Reinhold William C, Holbeck Susan L, Simon Richard M, Doroshow James H, Pommier Yves, Meltzer Paul S

Abstract excerpt

The NCI-60 cell lines are the most frequently studied human tumor cell lines in cancer research. This panel has generated the most extensive cancer pharmacology database worldwide. In addition, these cell lines have been intensely investigated, providing a unique platform for hypothesis-driven research focused on enhancing our understanding of tumor biology. Here, we report a comprehensive analysis of coding...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Cell Line, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Screening Assays, Antitumor

Share to Genetic Variation

Share to Mutation

Share to Neoplasms

Share to Pharmacogenetics

Source

Open in PubMed Open full text

Identifiers

PMID: 23856246
DOI: 10.1158/0008-5472.CAN-12-3342
PMCID: PMC4893961

Genes

ATAD5
BRAF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The exomes of the NCI-60 panel: a genomic resource for cancer biology and systems pharmacology.PMID 23856246Read ↗

NCI-60 whole exome sequencing and pharmacological CellMiner analyses.Semantic proximity Read ↗

Using CellMiner 1.6 for Systems Pharmacology and Genomic Analysis of the NCI-60.Semantic proximity Read ↗

Exome sequencing reveals comprehensive genomic alterations across eight cancer cell lines.Semantic proximity Read ↗

RNA Sequencing of the NCI-60: Integration into CellMiner and CellMiner CDBSemantic proximity Read ↗

MUSTARD-a comprehensive resource of mutation-specific therapies in cancer.Semantic proximity Read ↗

Mutation analysis of 24 known cancer genes in the NCI-60 cell line set.Semantic proximity Read ↗

Whole-exome sequencing of 79 xenografts as a potential approach for the identification of genetic variants associated with sensitivity to cytotoxic anticancer drugs.Semantic proximity Read ↗

Integrated next-generation sequencing analysis of whole exome and 409 cancer-related genes.Semantic proximity Read ↗

A comprehensive transcriptional portrait of human cancer cell lines.Semantic proximity Read ↗

Comparison of whole-exome, whole-transcriptome genomic profiling and targeted sequencing with 50-gene panels in advanced solid tumorsSemantic proximity Read ↗

rcellminer: exploring molecular profiles and drug response of the NCI-60 cell lines in RSemantic proximity Read ↗

Elucidating the cancer-specific genetic alteration spectrum of glioblastoma derived cell lines from whole exome and RNA sequencing.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.